GlassScriptPhysician profile
Julie M Keller
NPI 1619134285
$29,106.60
in general payments reported to CMS, 2019-2025
16 companies · $249 in 2025
The $249 reported for 2025 was less than what a typical Orthopaedic Trauma provider received nationally (typical 2025 total: $1,227).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,740 · 2020: $4,608 · 2021: $2,980 · 2022: $8,450 · 2023: $7,305 · 2024: $775 · 2025: $249.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,800 · Food and Beverage: $874 · Travel and Lodging: $655.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,800.00 |
| Food and Beverage | $873.65 |
| Travel and Lodging | $655.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $16,371.86 | 2019-2024 | Axsos, T2 Alpha, Gamma |
| Synthes USA Products LLC | $6,506.50 | 2020-2021 | |
| Synthes Gmbh | $4,717.68 | 2019-2022 | |
| Medical Device Business Services, INC. | $900.00 | 2020 | |
| Fusion Orthopedics USA, LLC | $128.10 | 2025 | |
| Depuy Synthes Sales INC. | $123.63 | 2020-2023 | Chia Percpasser, Milagro, Vapr |
| Kerecis Limited | $99.90 | 2022-2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Globus Medical, INC. | $44.60 | 2022 | |
| Dynasplint Systems INC. | $42.78 | 2025 | Dynasplint |
| Zimmer Biomet Holdings, INC. | $41.47 | 2022 | |
| Innovation Technologies INC | $35.24 | 2020 | |
| Sanara Medtech INC. | $30.91 | 2024 | Celleraterx |
| Bioventus LLC | $24.09 | 2024 | Exogen Ultrasound Bone Healing System |
| Boston Scientific Corporation | $20.00 | 2019 | |
| My01 INC. | $19.84 | 2023 | My01 Continuous Compartmental Pressure Monitor |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$68,875.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julie Keller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.